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Objective: Previous studies have reported that patients with irritable bowel syndrome (IBS) show high neuroticism.
However, the precise association between the IBS subtypes and the degree of neuroticism in younger populations
is largely unknown. We tested our hypothesis that subjects with diarrhea-predominant IBS may have a higher
degree of neuroticism than subjects without IBS or those with other subtypes of IBS. We also verified the additional
hypothesis that the severity of neuroticism might be correlated with the severity of IBS in younger populations.
Methods: We conducted a cross-sectional survey of 557 university students, ranging in age from 18 to 21 years.
Presence/ absence of IBS and determination of the IBS subtype was by the Rome II Modular Questionnaire, while
the severity of IBS was determined by the IBS severity index (IBS-SI). The degree of neuroticism was evaluated using
the Maudsely Personality Inventory (MPI). The presence/absence of psychological distress was measured with the
K6 scale.
Results: Neuroticism scores in the subjects with diarrhea-predominant IBS were significantly higher than those in
the non-IBS subjects or subjects with constipation-predominant IBS. The neuroticism scores were significantly
correlated with the IBS-SI scores in all subjects with IBS.
Conclusion: These results suggest that neuroticism is involved in the pathophysiology of IBS in young subjects,
especially in that of the diarrhea-predominant subtype.
Keywords: Personality, Irritable bowel syndrome, Depression, Neuroticism, Brain- gut interactionsIntroduction
Irritable bowel syndrome (IBS) is a functional gastro-
intestinal disorder not associated with major organic dis-
eases [1,2]. The characteristic pathophysiological
features of IBS are dysmotility of the lower gastrointes-
tinal tract [3], visceral hypersensitivity [4], and psycho-
logical abnormalities [5]. A previous study focusing on
the psychological abnormalities in IBS reported that the
gastrointestinal symptoms of IBS worsened with aggra-
vation of the psychological state and that they improved
with recovery of the psychological state [5]. Several
epidemiologic studies have revealed that the prevalence
rates of depression and anxiety are higher in IBS patients
than those in healthy persons [6-8]. In a study that* Correspondence: sfukudo@med.tohoku.ac.jp
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reproduction in any medium, provided the orexamined the depressive symptoms in 80 IBS patients
and 21 healthy persons aged 21 years to 65 years old,
the average scores for depression were higher in the
group with constipation-predominant IBS (C-IBS) and
the IBS group with alternating diarrhea and constipation
(A-IBS) than in the healthy persons; however, no signifi-
cant difference in the score for depression was seen
between the subjects with diarrhea-predominant IBS
(D-IBS) and healthy persons [9].
Among the several known personality traits, neuroticism
has been suggested as a risk factor for the development of
IBS [10-13]. In the study conducted in 41 IBS patients and
2000 healthy persons aged 41 to 49 years old by Palmer
et al. using [10] Eysenck’s index (Maudsely Personality
Inventory: MPI), the average score for neuroticism was
higher in the IBS patients than that in healthy persons. In a
study performed in 60 IBS patients (average age ± standard
deviation: 29 ± 7) and 55 healthy persons (average age ±l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sic Personality Inventory (MMPI-2), Mousavinasab et al.
[11] reported a higher average score for hypochondriasis in
the IBS patients than that in the healthy persons. Farman
et al. [12] showed that the average score for neuroticism in
an evaluation conducted using the NEO Five-Factor Inven-
tory (NEO-FFI) was significantly higher in the C-IBS group
(33 patients) than the scores in the groups with other sub-
types of IBS (71 with D-IBS patients and 46 A-IBS
patients). In the study conducted by Tanum et al. [14] in 56
patients with functional gastrointestinal disorders (FGIDs),
including 31 IBS patients and 55 age-matched healthy per-
sons (age range: 18–70 years old), the average score for
neuroticism on the NEO Personality Inventory (NEO-PI)
was higher in the FGID patients than that in the healthy
persons. Thus, neuroticism may indeed play some role in
the pathophysiology of IBS.
In an epidemiologic survey of 10,000 Japanese adults
aged over 20 years old, the prevalence rate of IBS in per-
sons aged 20–29 years, as diagnosed based on the
ROME-III criteria, was 14% among males and 22%
among females [15]. In persons aged 30 years or over,
the prevalence rate of IBS decreased gradually with
increasing age [15]. In an investigation of 1,087 Japanese
college students with an average age of 20 years (SD ±
2), the prevalence rate of IBS, as diagnosed based on the
ROME-III criteria, was 19% overall, 17% in males, and
20% in females [16]. The above reports suggest that the
prevalence of IBS may be higher in college students as
compared with that in older age groups, which warrants
further analysis.
Despite the earlier studies mentioned above, there is
no evidence yet to show that neuroticism is a risk factor
for the onset of any subtype of IBS in young patients.
Also, no study has been performed yet to determine the
relationship between the severity of neuroticism and the
severity of IBS among subjects with IBS. Investigation of
the relationship between the severity of neuroticism and
the severity of IBS in subjects with each subtype of IBS
may clarify the physiological relationship between neur-
oticism and the development of gastrointestinal symp-
toms. Neuroticism has been linked to the development
of mood and anxiety disorders [17,18]. Anxiety has been
shown to play a role in patients with diarrhea-
predominant IBS [19]. Therefore, neuroticism may be
closely related to the development of D-IBS. In this
research, we attempted to verify the following two
hypotheses in university students, who represent the
young population.
1) In the young population, subjects with diarrhea-
predominant IBS show a higher degree of
neuroticism than subjects not suffering from IBS or
subjects with other IBS subtypes.2) In the young population, the neuroticism score is
correlated with the severity of IBS.
Method
Subjects
We conducted a cross-sectional study of 655 university
students, ranging in age from 18 years to 21 years. Of
the 655 subjects, 11 refused to provide consent for the
use of their data for research/participation in this study,
and 87 did not respond to the questionnaire. We there-
fore analyzed the data of the remaining 557 persons who
answered all the items of the questionnaire (Figure 1).
Of these 557 subjects, 143 (26%) were diagnosed as
having IBS based on responses to the IBS screening
questionnaire described below.
Measurements
The Rome II Modular Questionnaire (RIIMQ)
Rome II criteria, described below, are widely used for
the diagnosis of IBS [20]: at least 12 weeks, which need
not be consecutive, during the preceding 12 months
during which the patient suffered from abdominal dis-
comfort or pain satisfying the following three features:
(1) relieved by defecation, (2) onset associated with a
change in the stool frequency, and/or (3) onset asso-
ciated with a change in the form (appearance) of the
stool. The following symptoms cumulatively support the
diagnosis and subtyping of IBS: (a) fewer than 3 bowel
movements a week; (b) more than 3 bowel movements a
day; (c) hard or lumpy stools; (d) loose (mushy) or
watery stools; (e) straining during a bowel movement; (f )
urgency (having to rush to have a bowel movement); (g)
feeling of incomplete evacuation; (h) passage of mucus;
(i) bloating or feeling of abdominal distension. D-IBS is
defined by one or more of b, d or f and none of a, c or
e, or 2 or more of b, d, or f and one of a or e. C-IBS is
defined by one or more of a, c, or e and none of b, d or
f, or 2 or more of a, c, or e and one of b, d or f. IBS
patients not fulfilling the aforementioned criteria for
D-IBS or C-IBS were defined as having A-IBS in this
study. RIIMQ has been reported as a reliable tool for
epidemiological surveys [21]. The Japanese version of
the RIIMQ is a questionnaire that is used for both diag-
nosis of IBS and for determination of the subtype of IBS
[22].
IBS severity
The Japanese version [22] of the IBS severity index (IBS-
SI) [23] was used in this study to assess the severity of
the lower gastrointestinal symptoms and the degree of
impairment of the quality of life by the IBS. This instru-
ment is composed of five items, with the possible total





Did not consent (n=11)
Refused to participate (n=11)
Excluded (N=87)
Did not completed the questionnaire (n=87)
Potential participants assessed for eligibility (n=655)
Consented to participate (n=644)
Eligible (n=557)
Figure 1 Study flow. Of 655 subjects, 11 did not provide consent for participation, and 87 did not respond to the questionnaire. We analyzed
the data of the remaining 557 persons who answered all the items of the questionnaire.
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bowel movements, and the quality of life.
Psychological distress
The six-item K6 [24] was used in this study to evaluate
the presence/absence of psychological distress in the
subjects. The K6 has been developed to identify persons
who are at a risk of developing mental states such as
depression and anxiety [25]. The K6 total score can
range from 0 to 24, and patients with scores of 13 or
greater are categorized as suffering from psychological
distress.
Personality
The Maudsely Personality Inventory (MPI) [26] is a
measure used to assess personality in two dimensions,
namely, neuroticism and extroversion/introversion. It is
composed of 80 items calling for a yes/no response;
Extroversion (E): 24-items; Neuroticism (N): 24-items;
Lie (L): 20-items; Filler items: 12-items.
Procedure
The questionnaire survey was given during an academic
session in the classroom. First, we explained the research
content and provided both a written and verbal explan-
ation about the intended use of the data. In addition, we
explained that persons not providing consent for partici-
pation in the study would not be placed at any disadvan-
tage whatsoever. We only included the data of those
students who agreed to cooperate with the research for
the analysis in this study.
Data analysis
Data are presented as means ± standard deviation (SD).
An unpaired t-test was used to compare any two groups.Correlation coefficients were calculated by determin-
ation of the Pearson’s correlation coefficients. Chi-
square test was used to evaluate differences in
percentages. One-way ANOVA was performed to com-
pare data between groups. One-way ANOVA was per-
formed for between group comparisons. SPSS, version
18.0, was used for the statistical analyses.
Ethics
The study protocol was approved by the Ethics Commit-
tee of Nagasaki University, and informed consent was
obtained from all the subjects.
Results
The demographic data of the study subjects and the refer-
ence values in healthy persons established in a previous
study are shown in Table 1 [16,27-31]. Males comprised
59% of all subjects (95% confidence interval (CI), 55 to
63%). The mean (±SD) age of the subjects was 19 (±1)
years. The prevalences of D-IBS, C-IBS and A-IBS in the
study population were 4% (95% CI, 3 to 6), 9% (95% CI, 7
to 12) and 12% (95% CI, 10 to 15), respectively. In
addition, the prevalence of psychological distress in the
overall study population was 7% (95% CI, 5 to 9), consist-
ent with the finding of a previous study [30].
The scores for each of the evaluated items in the IBS
group and non-IBS group are shown in Table 2. The
proportion of males/females in the non-IBS group was
64%/36%, and that in the IBS group was 48%/52%, with
a significant difference in the proportion of males/
females between the two groups (p = 0.0001). Scores on
the IBS-SI in the IBS group (53.9 ± 50.2) were signifi-
cantly higher than those in the non-IBS group (27.3 ±
39.8, p = 0.0001). Scores on K6 in the IBS group (6.7 ±
5.0) were also significantly higher than those in the non-
Table 1 Demographic data and reference values
Variables All subjects (n = 557)
(95% CI)
Reference value (general population (95% CI))
Sex (male (%)) 59 (55–63) 47 (36–45) Sugaya and Nomura[16]
Age 19 ± 1 (19–19) - -
IBS+ (%)a 26 (22–30) 14 (12–15) Kubo M, et al. [27]
D-IBS (%)b 4 (3–6) 4 (−) Kubo M, et al. [27]
C-IBS (%)c 9 (7–12) 3 (−) Kubo M, et al. [27]
A-IBS (%)d 12 (10–15) 3 (−) Kubo M, et al. [27]
IBS-SI 34.1 ± 44.2 (30.4-37.8) 30 (−)g Tana C, et al. [28]
K6e,f 5.4 ± 4.5 (5.0-5.7) 3.6 ± 3.9 (−) Sakurai K, et al. [29]
Persons with psychological distress (%)g 7 (5–9) 7 (7–7) Kuriyama S, et al. [30]
MPI - - -
Extroversion 27.2 ± 10.3 (26.3-28.0) 27. 2 ± 7.0 (−) Iwawaki, S et al. [31]
Neuroticism 21.6 ± 10.7 (20.7-22.5) 21.6 ± 7.9 (−) Iwawaki, S et al. [31]
Lie score 13.4 ± 5.8 (12.9-13.8) 13.4 ± 5.1 (−) Iwawaki, S et al. [31]
Data are expressed as mean ± standard deviation. CI, confidence interval.
a-e,g The numerical values represent the percentage of the total number of participants, namely, IBS patients plus healthy persons.
fPersons with a score of ≥13 points (out of a total 24 points) on the K6 were defined as experiencing psychological distress.
The data (score) represent median values.
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scores on the IBS-SI and K6 were seen even after adjust-
ment for the sex distribution (p = 0.0001 for all). The
percentage of persons with psychological distress was
significantly higher in the IBS group than that in the
non-IBS group (11% vs. 5%, p = 0.0081).
The scores for each of the evaluated items in the non-
IBS group and the groups with each subtype of IBS are
shown in Table 2. The main effects were seen in the
scores on the IBS-SI (F (3,553) = 14.1, p = 0.0001) and





Sex (male (%)) 64 48 §
Age 19 ± 1 19 ± 1
IBS-SI 27.3 ± 39.8 53.9 ± 50.2 †





Extroversion 27.6 ± 10.2 25.8 ± 10.4
Neuroticism 21.4 ± 10.8 22.4 ± 10.4
Lie score 13.3 ± 5.7 13.4 ± 6.0
aPersons with scores of ≥13 points (out of a total 24 points) on the K6 were defined
bValues are the percentages of the total number of participants (i.e., IBS group plus
cOne-way ANOVA was performed using the data from the non-IBS group, and the g
†p < 0.01 vs. non-IBS group; *p < 0.05 and **p < 0.01 vs. non-IBS group, unpaired t
§p< 0.01 vs. non-IBS group, chi square test.
¶p < 0.05 vs. C-IBS group, unpaired t-test.ANOVA. The percentage of persons with psychological
distress was 13% in the D-IBS group, 6% in the C-IBS
group, and 15% in the A-IBS group, and significant
differences among the three groups were revealed by the
chi-square test (χ2 = 10.5, p = 0.0146). Scores on the
IBS-SI in all of the D-IBS (47.9 ± 39.5, p = 0.0109),
C-IBS (51.6 ± 56.0, p = 0.0002) and A-IBS (57.6 ± 49.3,
p = 0.0001) groups were significantly higher than the
score in the non-IBS group (27.3 ± 39.8). Scores on K6
in the D-IBS group (8.3 ± 5.1, p = 0.0001) and the A-IBS
group (7.1 ± 5.4, p = 0.0001) were significantly highers in the personality scales
IBS subgroup p valuec
D-IBS C-IBS A-IBS
(n = 24) (n = 50) (n = 69)
58 32 55 p = 0.0001
19 ± 1 19 ± 1 19 ± 1 p = 0.1479
47.9 ± 39.5 ** 51.6 ± 56.0 ** 57.6 ± 49.3 ** p = 0.0001
8.3 ± 5.1 ** 5.5 ± 4.0 7.1 ± 5.4 ** p = 0.0001
13 6 15 p = 0.0001
- - - -
25.3 ± 10.8 27.1 ± 9.2 25.1 ± 11.2 * p = 0.2228
26.0 ± 9.4 * ¶ 20.5 ± 11.5 22.5 ± 9.6 p = 0.1430
12.4 ± 5.8 14.1 ± 6.6 13.3 ± 5.7 p = 0.6855
as experiencing psychological distress.
non-IBS group).
roups with the diarrhea-type, constipation-type and alternating-type IBS.
-test.
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for extroversion as assessed by the MPI in the A-IBS
group were significantly lower than those in the non-IBS
group (25.1 ± 11.2 vs. 27.6 ± 10.2, p = 0.0305). Scores of
neuroticism in the D-IBS group (26.0 ± 9.4) were signifi-
cantly higher than those in the non-IBS group (21.4 ±
10.8, p = 0.0182). Furthermore, the scores for neuroti-
cism in the D-IBS (26.0 ± 9.4) were significantly higher
than those in the C-IBS group (20.5 ± 11.5, p = 0.0183).
The differences in the scores on the IBS-SI and K6, and
in the scores for extroversion, and neuroticism, between
the two groups were seen even after adjustment for the
sex distribution (p = 0.0001 for all).
A significant correlation was observed between the
scores for neuroticism and the IBS-SI scores in all the
subjects (p = 0.0001), as shown in Figure 2. A significant
correlation was observed between the degree of neuroti-
cism and the IBS-SI score in the D-IBS patients
(r = 0.21, p = 0.0001), as shown in Figure 3. The corre-
sponding correlation was r = 0.12 (p < 0.01) in the C-
IBS group, r = 0.09 (p < 0.05) in the A-IBS group, and
r = 0.15 (p < 0.01) in the non-IBS group, both represent-
ing only weak correlations. There was no significant
correlation between the scores for extroversion and the
IBS-SI scores.
Discussion
The results of our cross-sectional study performed in a
young population of university freshmen revealed higher
degrees of neuroticism in patients with D-IBS, diagnosed
based on the ROME criteria, than in subjects not suffer-



















Figure 2 Correlation between neuroticism and the total score of the
was observed between the score for neuroticism and the IBS-SI score in all
r = 0.12 (p = 0.0001) in the C-IBS group and r = 0.09 (p = 0.0440) in the A-
significant correlation between the scores for extroversion and the IBS-SI scTherefore, hypothesis 1 was supported. Furthermore, the
correlation between the degree of neuroticism and the
severity of IBS also supported hypothesis 2.
A previous report indicated that among patients with
IBS, the severity of neuroticism was higher in patients
with C-IBS than that in patients with other subtypes of
IBS [12]. However in this study, in contrast to the afore-
mentioned report, the neuroticism score was higher only
in the D-IBS group as compared with that in the non-
IBS group. According to another previous study, while
the scores for depressive mood were higher in the C-IBS
and A-IBS groups than the score in healthy people, the
scores did not differ significantly between the D-IBS
group and healthy persons [9]. Furthermore, a survey of
1,087 Japanese college students revealed no differences
in the average scores for depressive mood between
patients with D-IBS or C-IBS and healthy persons [16].
Although Sugaya and Nomura reported that males com-
prised 64% of the D-IBS group but only 22% of the C-
IBS group in their series [16], males in this study
accounted for 58% and 32% of the patients in the D-IBS
and C-IBS groups, respectively. It has been reported
that, among Japanese adults, the prevalence of psycho-
logical distress, as judged by K6, is higher in females
than in males [30], and that the prevalence rate of IBS is
higher in females than in males [32]. Based on the
higher percentage of females in the D-IBS group in this
study, such a result may have been output in this study.
The following reason is speculated to explain the cor-
relation between the neuroticism scores and the scores
on IBS-SI in the D-IBS group in this study. Neuroticism
in patients with depression has been reported to increase250 300 350
All subjects (n = 557)






IBS severity index in the study population. A significant correlation
the subjects (r = 0.15, p = 0.0001). The corresponding correlation was
IBS group, both representing weak correlations. There was no
ores.
D-IBS (n = 24)




















Figure 3 Correlation between the score for neuroticism and the total score of the IBS-SI in the D-IBS subjects. A significant correlation
was observed between the scores for neuroticism and the IBS-SI scores in the D-IBS subjects (r = 0.21, p = 0.0001).
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depression, the hypothalamic-pituitary-adrenocortical
(HPA) axis is reported to be activated [35-37]. Therefore,
the HPA-axis is assumed to also be activated in subjects
with a high severity of neuroticism. In animal experi-
ments, corticotropin-releasing hormone (CRH) has been
reported to increase the fecal pellet output and exagger-
ate colonic motility [38]. A previous study reported HPA
hyperactivity in adults with a high degree of neuroticism
[39]. In IBS patients, exogenous CRH administration
aggravates the brain-gut axis [40] and administration of
CRH antagonists normalizes the axis [41]. Therefore, a
high degree of neuroticism may aggravate the symptom
of diarrhea by worsening the depressive mood and en-
hancing the activity of the HPA-axis, especially in
younger age groups. Furthermore, in this study, subjects
were categorized as having/not having IBS based on the
results of a questionnaire, and not by a physician. Thus,
the rate of IBS identified in this study may be an over-
estimate as compared with the potential diagnosis rate
by a physician. If the prevalence rate of IBS found in this
study were indeed higher than the potential prevalence
rate determined based on a physician’s diagnosis, it is
possible that our results may include the data of persons
with relatively minor symptoms. Therefore, if the study
were conducted only with patients with physician-
diagnosed IBS, the relationship between psychological
traits and the severity of IBS may have become more ap-
parent, and the relationship may have been underesti-
mated in this study.
In this study, no difference in the neuroticism score
was observed between the subjects with and without
IBS. By contrast, in some earlier studies, higherneuroticism scores have been reported in patients with
IBS than in subjects without IBS [10,11]. A possible
major reason for the absence of any significant differ-
ence in the neuroticism score between subjects with and
without IBS in our study was that the subjects were all
freshmen college students. The frequency of major
depression has been reported to increase with age [42].
Neuroticism in patients with depression has been
reported to raise the score for depressive mood [33,34].
Therefore, the lack of increased score for neuroticism in
the IBS subjects overall, and of a correlation between
the degree of neuroticism and the severity of IBS in the
overall subject population in this study may suggest a
subliminal role of neuroticism in IBS pathophysiology.
Moreover, the hypothesis of involvement of neuroticism
in the development of IBS may have originated from the
relationship between the degree of neuroticism and that
of the D-IBS phenotype in the younger generation.
The strength of this study is that it examined the in-
volvement of neuroticism in college students with each
subtype of IBS, and it was the first study to do so in col-
lege students. There are three limitations to this study.
First, this research targeted only one university. The
prevalence rates of IBS differ by culture [43,44]. The target
university is located in a medium-sized city on the island
of Kyushu in western Japan. Therefore, it is unknown
whether the results can be extrapolated to Japanese uni-
versity students in general. Second, since this study is a
cross-sectional study, it could not be judged how the pres-
ence/degree of neuroticism influenced the severity of diar-
rhea in the subjects. Therefore, prospective studies are
required. Third, although we evaluated psychological dis-
tress in the subjects using K6 in this study, we did not
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of adequate evaluation of depression in the present study
might limit the interpretation of the obtained results.
In conclusion, in a young study population in Japan,
patients with D-IBS showed higher degrees of neuroti-
cism as compared to subjects not suffering from IBS and
subjects with C-IBS. Furthermore, the degree of neuroti-
cism was correlated with the severity of IBS in the young
subjects. This suggests that neuroticism may be involved
in the onset and aggravation of IBS, and therapeutic
approaches for D-IBS should take this finding into
consideration.
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